“Not everything that is faced can be changed, but nothing can be changed until it is faced.”
– James Baldwin
Brooke Kosich is a healthcare executive whose career has been defined by a steadfast commitment to improving patient outcomes and advancing the frontiers of medical technology. With more than fourteen years of experience spanning medical devices, commercialization, and clinical leadership, she has become a trusted voice in shaping healthcare strategies across multiple global markets. Her journey reflects a unique blend of clinical expertise, sales acumen, and visionary leadership that positions her as a valuable asset to organizations seeking to innovate and grow within the complex world of MedTech.
Brooke’s professional journey began with a strong foundation in clinical exercise physiology, earning a Master of Science degree from Ball State University after completing her Bachelor of Science in Kinesiology and Exercise Science at the University of Indianapolis. This academic grounding provided her with both a scientific and patient-centered perspective, which later became the cornerstone of her approach in medical device leadership. Early in her career, she served as Director of Cardiac and Pulmonary Rehabilitation at Tomball Regional Medical Center, where she developed and managed programs designed to restore patient health and improve long-term outcomes. This role gave her a firsthand understanding of the clinical challenges faced by patients and providers, shaping her ability to bridge the gap between innovation and real-world application.
In 2015, Brooke joined Medtronic, one of the world’s leading medical technology companies, where she would spend over six years ascending through multiple leadership roles. As a Clinical Specialist and later Senior Clinical Specialist in Cardiac Rhythm and Heart Failure (CRHF), she honed her technical expertise in complex cardiac therapies while driving adoption among clinicians. Her performance quickly distinguished her as a top performer, leading to promotions into commercial leadership roles, including Stroke Specialist and Stroke Solutions Manager. In these capacities, she not only exceeded quotas but also earned recognition as a President’s Club Winner, a distinction that underscored her ability to deliver results in highly competitive environments.
Her transition into stroke solutions leadership represented a critical inflection point in her career. Here, Brooke combined her deep clinical acumen with a consultative sales approach, educating physicians, guiding hospital systems, and advocating for cutting-edge stroke therapies that ultimately saved lives. She became known not only as a results-driven professional but also as a trusted partner to clinicians who valued her insights and ability to translate complex science into practical applications. Her reputation as a leader who could balance commercial priorities with patient needs cemented her credibility within Medtronic and beyond.
In 2021, Brooke expanded her expertise into the rapidly evolving field of artificial intelligence in healthcare, joining TeraRecon, Inc., a global leader in advanced visualization and AI-powered imaging solutions. As Global Artificial Intelligence Sales Specialist and later Director of AI Commercialization, she led the adoption of AI technologies across hospitals and health systems worldwide. Her work involved bridging the gap between engineering innovation and clinical utility, ensuring that new technologies could be effectively integrated into workflows to improve diagnostic accuracy and patient care. This period further reinforced her ability to operate at the cutting edge of healthcare, while also strengthening her global exposure through significant experience across Europe, Asia, the Middle East, and the Asia-Pacific region.
Brooke’s return to Medtronic in 2025 as Senior Therapy Expansion Leader reflects her enduring passion for medical devices and patient-centered innovation. In this role, she continues to leverage her clinical knowledge and commercialization expertise to expand access to therapies in cardiovascular and neurovascular specialties. Her efforts are not only advancing Medtronic’s mission but also transforming care pathways by ensuring that evidence-based therapies are adopted widely and effectively. She thrives at the intersection of clinical insight and business strategy, uniquely positioned to influence both the boardroom and the operating room.
Beyond her professional accomplishments, Brooke’s career has been guided by a deep personal mission: to save lives and elevate patient outcomes. She is passionate about mentoring rising professionals, fostering leadership talent, and encouraging women in MedTech to pursue impactful careers. Her philanthropic interests align with her personal commitment to giving back, reflecting her belief that true leadership extends beyond professional accolades to meaningful contributions in community and society.
Her achievements have been recognized through numerous honors, including being named a Marquis Who’s Who Honored Listee in 2025, a testament to her influence and leadership within the MedTech sector. She has also contributed to scholarly work, with her publication in the Journal of Gerontology exploring the influence of COX inhibitors on muscle physiology in older adults. These contributions highlight her intellectual rigor and commitment to advancing scientific and clinical knowledge.
What sets Brooke apart is her ability to operate fluidly across disciplines—clinician, strategist, and commercial leader—while maintaining an unwavering focus on patient care. She is as comfortable in the boardroom presenting to executives as she is in the hospital setting advising clinicians. Her international exposure has equipped her with a nuanced understanding of diverse healthcare systems, while her leadership in both MedTech and AI demonstrates her adaptability and forward-thinking approach in industries undergoing rapid transformation.
At her core, Brooke is motivated by the belief that meaningful change in healthcare requires courage, vision, and collaboration. Her career embodies this philosophy, with each chapter building upon the last to form a legacy of leadership defined by measurable impact, transformative growth, and a relentless drive to ensure patients receive the care they deserve. She stands as a compelling candidate for board service, where her voice, insight, and experience can shape the future of medical technology and beyond.
Character:
Brooke exemplifies integrity and resilience, consistently demonstrating a commitment to ethical leadership and patient-centered values. She approaches challenges with humility and determination, earning trust from both colleagues and clinical partners. Her character is marked by a balance of professional excellence and genuine compassion.
Knowledge:
With over fourteen years of experience across medical devices, commercialization, and artificial intelligence in healthcare, Brooke brings unparalleled industry knowledge. Her academic background in clinical physiology reinforces her credibility as a subject matter expert. This depth of expertise allows her to guide strategic decisions that align innovation with patient outcomes.
Strategic:
Brooke is a forward-thinking leader who combines clinical insight with commercial strategy to drive organizational growth. She has consistently translated vision into execution, whether expanding therapy adoption, launching AI technologies, or leading cross-functional teams. Her ability to anticipate market needs positions her as a strategic advisor capable of shaping long-term success.
Communication:
Known for her clarity and influence, Brooke excels at engaging diverse stakeholders from executives to clinicians. She has a proven ability to simplify complex scientific concepts into actionable insights, ensuring alignment across disciplines. Her communication style builds trust, fosters collaboration, and inspires teams toward shared goals.
